Page 152 - Mployee Wellness Programs News Today

This lack of monitoring is a serious problem—both for patients and for the overall healthcare system. The data show that in a typical dialysis center, each patient will suffer an average of 1.7 access blockages per year.

Invite-only, in-person event series for industry leaders like you. Join us to uncover product and ML innovation with our guests and speakers.

Suzette Zuena is her own best advertisement for weight loss. Zuena, the “founder/visionary” of LH Spa & Rejuvenation in Livingston and Madison, New Jersey, has dropped 30 pounds. Her husband has lost 42 pounds. “We go out a lot,” Zuena said of the pair’s social routine. “People saw us basically shrinking.” They would ask how the couple did it. Her response: Point people to her spa and a relatively new type of medication — GLP-1 agonists, a class of drug that’s become a wei...

Automation, AI, and machine learning can all be used to identify issues that lead to denials, streamline the patient billing process, reduce manual processes, and provide real-time data to quickly process claims.

Medical robotics startup Noah Medical recently closed a $150 million Series B funding round. The company's robotic platform, called the Galaxy System, was designed to help physicians find, biopsy and diagnose lung cancer lesions with more ease and confidence.

Gary Frazier, CEO of Worksite Labs, a full-service diagnostic testing company shared insights on the healthcare’s industry’s move into a decentralized approach.

Clear, a company founded to help travelers breeze through airport security lines, is now pursuing partnerships with health systems. Georgia-based Wellstar Health System recently announced it will use the company's identity verification technology to give patients secure and seamless access to their personal health information.

Talkiatry is now available to Horizon Healthcare Services’ commercial members at no additional cost, giving 3.6 million people access to the virtual mental health services. The company treats patients ages 5 years and older for conditions including anxiety, depression and bipolar disorder. 

The FDA approved Omisirge, an allogeneic cell therapy from Gamida Cell that could improve access to stem cell transplants as treatments for blood cancers. The biotech makes its therapy from umbilical cord blood.

Anita Nelsen, Senior Vice President of Clinical Trial Operations at Allucent, shares her insights on how to navigate the drug development landscape.